MG
IMUX icon

Marex Group’s Immunic IMUX Stock Holding History

Marex Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,270
Closed -$17.5K – 1142
2025
Q4 		$17.5K Buy
3,270
+1,020
+45% +$7.47K ﹤0.01% 948
2025
Q3 		$19.8K Hold
2,250
– – ﹤0.01% 822
2025
Q2 		$15.7K Hold
2,250
– – ﹤0.01% 629
2025
Q1 		$24.5K Hold
2,250
– – ﹤0.01% 658
2024
Q4 		$22.5K Buy
+2,250
New +$28.4K ﹤0.01% 657

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Marex Group's IMUX Position: Q1 2026 in Review

Marex Group sold out of Immunic (IMUX) in Q1 2026, closing a stake of 3,270 shares — an estimated $17.5K sold.

Marex Group first reported a position in IMUX in Q4 2024 and held it in 5 quarters. The position peaked at $24.5K in Q1 2025. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Marex Group reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • Marex Group sold 3,270 Immunic shares in Q1 2026, an estimated $17.5K.
  • Marex Group first reported a position in Immunic in Q4 2024 and held it in 5 quarters.
  • Marex Group's Immunic position peaked at $24.5K in Q1 2025.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.